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Abstract
Background: Collaborative-care management is an evidence-based practice for improving depression outcomes in
primary care. The Department of Veterans Affairs (VA) has mandated the implementation of collaborative-care
management in its satellite clinics, known as Community Based Outpatient Clinics (CBOCs). However, the
organizational characteristics of CBOCs present added challenges to implementation. The objective of this study
was to evaluate the effectiveness of evidence-based quality improvement (EBQI) as a strategy to facilitate the
adoption of collaborative-care management in CBOCs.
Methods: This nonrandomized, small-scale, multisite evaluation of EBQI was conducted at three VA Medical
Centers and 11 of their affiliated CBOCs. The Plan phase of the EBQI process involved the localized tailoring of the
collaborative-care management program to each CBOC. Researchers ensured that the adaptations were evidence
based. Clinical and administrative staff were responsible for adapting the collaborative-care management program
for local needs, priorities, preferences and resources. Plan-Do-Study-Act cycles were used to refine the program
over time. The evaluation was based on the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance)
Framework and used data from multiple sources: administrative records, web-based decision-support systems,
surveys, and key-informant interviews.
Results: Adoption: 69.0% (58/84) of primary care providers referred patients to the program. Reach: 9.0% (298/3,296)
of primary care patients diagnosed with depression who were not already receiving specialty care were enrolled in
the program. Fidelity: During baseline care manager encounters, education/activation was provided to 100% (298/
298) of patients, barriers were assessed and addressed for 100% (298/298) of patients, and depression severity was
monitored for 100% (298/298) of patients. Less than half (42.5%, 681/1603) of follow-up encounters during the
acute stage were completed within the timeframe specified. During the acute phase of treatment for all trials, the
Patient Health Questionnaire (PHQ9) symptom-monitoring tool was used at 100% (681/681) of completed follow-
up encounters, and self-management goals were discussed during 15.3% (104/681) of completed follow-up
encounters. During the acute phase of treatment for pharmacotherapy and combination trials, medication
adherence was assessed at 99.1% (575/580) of completed follow-up encounters, and side effects were assessed at
92.4% (536/580) of completed follow-up encounters. During the acute phase of treatment for psychotherapy and
combination trials, counseling session adherence was assessed at 83.3% (239/287) of completed follow-up
encounters. Effectiveness: 18.8% (56/298) of enrolled patients remitted (symptom free) and another 22.1% (66/298)
responded to treatment (50% reduction in symptom severity). Maintenance: 91.9% (10/11) of the CBOCs chose to
sustain the program after research funds were withdrawn.
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Introduction
Collaborative-care management (CCM) is an evidence-
based practice that involves a multidisciplinary depres-
sion care team (e.g., primary care providers, nurse care
managers, pharmacists, psychologists, psychiatrists) pro-
viding guideline-concordant depression treatment in the
primary care setting. Numerous effectiveness studies
have demonstrated that CCM improves outcomes for
primary care patients treated for depression [1-10]. The
CCM model has been rolled out nationally in the United
States by the Department of Veterans Affairs (VA) Med-
ical Centers as part of the Primary Care/Mental Health
Integration Initiative [11].
More recently, the VA has encouraged the implemen-
tation of CCM in its Community Based Outpatient
Clinics (CBOCs), where 64% of veterans receive their
care [12], and mandated implementation in those cate-
gorized as large (5,000-10,000 patients) and very large (>
10,000 patients). Veterans treated at CBOCs have simi-
lar demographic characteristics as veterans treated at
VA Medical Centers (VAMCs) [13]. All CBOCs provide
primary care services, and most large and very large
CBOCs also provide specialty mental health services.
However, veterans treated in CBOCs have significantly
fewer mental health visits than do veterans treated at
VAMCs [14]. Twenty-six percent of CBOCs are private
clinical organizations contracting with the VA to pro-
vide primary care services to veterans [12]. Veterans
treated in contract CBOCs have significantly fewer men-
tal health visits than do veterans treated in VA-staffed
(i.e., owned and operated) CBOCs [15]. While CCM
could potentially address this disparity, there are numer-
ous barriers to implementingac o m p l e xc l i n i c a lp r o -
gram like CCM in small contract CBOCs.
The organizational characteristics of contract CBOCs
present added challenges to the implementation of
CCM. For example, contract CBOCs receive capitated
payments (a fixed amount per enrollee to cover a
defined scope of services) from the VA and, thus, must
consider the financial risk associated with depression
quality-improvement efforts. As a result, contract
CBOCs may be less willing to comply with VA quality-
improvement initiatives compared to VA-staffed clinics,
unless these initiatives are embedded into their legal
contracts. In addition, the majority of contract CBOCs
do not have on-site psychiatrists, and because half of
contract CBOCs are located in rural areas, [16]
recruiting psychiatrists to small contract CBOCs is typi-
cally not feasible. A previous randomized trial documen-
ted that the CCM model can be adapted using
telemedicine technologies to effectively improve out-
comes for patients treated in CBOCs without on-site
psychiatrists [17]. While there is good evidence that tel-
emedicine-based CCM improves outcomes in contract
CBOCs, no implementation strategy is known to be
effective for this type of organizational context.
The overall goal of our research was to facilitate the
adoption of telemedicine-based CCM in contract
CBOCs. The Promoting Action on Research in Health
Services (PARiHS) framework proposes that successful
adoption of an evidence-based practice depends on (1)
evidence, (2) context, and (3) facilitation [18]. Evidence
includes results from randomized trials, as well as anec-
dotal evidence from clinical experience [19,20]. Context
includes both factors internal to the organization, such
as culture, climate, and capacity, [21-29] as well as
external forces, such as mandates and performance mea-
sures. Facilitation typically involves an integrated set of
implementation strategies to promote adoption. In this
study, we used a facilitation method known as evidence-
based quality improvement (EBQI). EBQI has been used
successfully to implement CCM in VA Medical Centers
[30]. Our specific objective was to test the feasibility of
EBQI as an implementation strategy for telemedicine-
based CCM in contract CBOCs. Results should inform
efforts to roll out complex evidence-based practices to
small satellite clinics of integrated healthcare systems.
EBQI was developed by Rubenstein and colleagues
based on the findings of the Mental Health Awareness
Project, which compared two quality-improvement stra-
tegies for depression in primary care [31,32]. Clinics
were randomized to either a top-down centralized qual-
ity-improvement model or a bottom-up locally driven
quality-improvement model [32] The top-down
approach involved centralized experts implementing
depression evidence-based practices, with some input
from local primary care staff. The bottom-up approach
involved local clinical staff implementing depression evi-
dence-based practices, with some input from experts.
The bottom-up quality-improvement teams had both
the best and worst outcomes in terms of fidelity to the
evidence base [32]. This finding suggests that the bot-
tom-up approach has the best potential for quality
improvement but is subject to substantial variation
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These findings are consistent with two well-designed
implementation studies that found that traditional con-
tinuous quality-improvement models do not improve
depression outcomes [33,34]. Qualitative analyses of the
Mental Health Awareness Project also indicated that the
top-down approach was more efficient, but the project
failed to attain buy-in from local clinicians and adminis-
trators [35]. In contrast, the bottom-up quality-improve-
ment approach promoted customization and buy-in but
was perceived to be overly time-consuming and ineffi-
cient (e.g., reinventing the wheel) [35]. Based on these
findings, the EBQI model was developed, which involves
both centralized strategic decision making and local tac-
tical decision making [35]. There is a growing consensus
among implementation experts [36-38] and frontline
clinicians and managers [32,35,39] that quality-improve-
ment strategies that incorporate both top-down and bot-
tom-up approaches hold the most promise for sustained
implementation of evidence-based practices.
In EBQI, both researchers (clinical experts, implementa-
tion experts) and local staff participate fully in the quality-
improvement process, with the researchers facilitating
rather than dictating implementation efforts [32,35,39].
Thus, EBQI is intended to foster a researcher/clinician
partnership that promotes buy-in from leadership [40,41].
Lack of support from leadership has been shown to be one
of the most important barriers to the implementation of
the CCM [42]. While emphasizing the involvement of out-
side experts and empirical evidence, EBQI stresses that an
organization’s own healthcare professionals and staff are
best positioned to improve their systems [40]. Clinicians
and administrators contribute the local knowledge needed
to tailor the evidence-based practice for their own particu-
lar needs and organizational capabilities. Researchers con-
tribute knowledge of the evidence base; ensure fidelity to
the evidence base; and supply materials, procedures, and
tools needed for successful implementation. In addition to
providing expertise, researchers in the EBQI model also
facilitate problem solving and provide ongoing technical
support for developing data collection/analysis tools, infor-
matics, and training materials. EBQI also emphasizes con-
tinuously revising the adaptede v i d e n c e - b a s e dp r a c t i c e
based on feedback during Plan-Do-Study-Act cycles and,
thus, should lead to adapted evidence-based practices that
are robust, user friendly, and feasible to deploy in real-
world practice settings. The primary objective of this
research was to test the feasibility of EBQI as a facilitation
strategy for implementing telemedicine-based CCM in
contract CBOCs.
Methods
This nonrandomized, small-scale, multisite evaluation of
EBQI was conducted at three VAMCs and their
affiliated CBOCs located in two regional Veterans Inte-
grated Service Networks (VISNs) in the United States.
The VAMCs participating in the implementation were
chosen based on their number of affiliated contract
CBOCs, their willingness to participate, and their poten-
tial for success as perceived by VISN leadership. The
three VAMCs were affiliated with 11 contract CBOCs.
Implementation strategy
Each of the three VAMCs had an EBQI team comprised
of stakeholders from mental health, primary care, and
the CBOCs, as well as the principal investigator. There
were no EBQI meetings involving team members from
multiple sites, although the principal investigator shared
solutions and tools across sites to increase implementa-
tion efficiency. Two of the VAMCs chose to have the
telemedicine-based CCM program operated by (i.e.,
administratively housed in) Mental Health, and the third
chose to have the program operated by Primary Care.
Especially important for this EBQI process was the
involvement and buy-in from leadership. Conceptual
models of implementation and theories of organizational
change strongly emphasize the importance of buy-in
from leadership [20,36,43]. Therefore, we designed our
EBQI process to engage and leverage clinic leadership.
However, personnel from the contract CBOCs could not
participate in the EBQI process directly because contract
CBOCs were not under the purview of an Institutional
Review Board and, therefore, could not be directly
engaged in research. Instead, the CBOC liaison at the
VAMC represented the view of CBOC stakeholders.
The initial Plan phase of the EBQI process involved
the localized tailoring of the telemedicine-based CCM
model to each VAMC and their CBOCs. Planning was
based on the Steps and Decisions Guide for Implement-
ing Depression CCM Models, which was developed spe-
cifically for the study [44]. The CCM experts utilized
their experience implementing depression research pro-
tocols and their knowledge of the depression and qual-
ity-improvement literature to ensure the adaptations to
the telemedicine-based CCM model were evidence
based. The chiefs of mental health/primary care, depres-
sion nurse care managers, other clinical leaders at the
VAMC, and the CBOC liaisons were responsible for
championing the implementation of the program and
adapting the telemedicine-based CCM for local needs,
priorities, preferences, and resources (within the fidelity
parameters defined by the CCM experts). For example,
each EBQI team developed unique criteria and methods
for identifying which patients were ineligible due to sub-
stance dependence. In addition, particular attention was
devoted to aligning the telemedicine-based CCM pro-
gram with the VA depression performance measures.
Performance measures are reported by the VA Central
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bonuses of VAMC Directors.
The Do phase at each of the VAMCs involved the
initial launch of the program, following a site visit from
the depression care manager at the CBOC considered to
have the highest chances for success. Beginning with
just one site allowed us to identify and resolve any
unforeseen problems before launching the program at
other CBOCs. It also allowed us to share any short-term
success experienced by this CBOC with the clinicians at
other CBOCs in order to promote provider adoption.
Subsequent Do phases involved the launches of the pro-
gram at the other CBOCs. The Study phase included
monthly EBQI conference calls with each site that dis-
cussed the implementation efforts. These calls were
informed by the data from the Net Decision Support
System (NetDSS) depression care manager workload
reports that provided information about patient enroll-
ment and fidelity to the care manager protocol (see
description below), as well as anecdotal experiences of
the care managers and their psychiatrist supervisors.
Any implementation problems were discussed during
the monthly conference calls and/or via email with the
stakeholders. The Act phases of the EBQI process
involved the refinement of the adapted telemedicine-
based CCM program based on the implementation
experiences and data collection described above as the
Plan-Do-Study-Act cycle was repeated.
Training and decision-support tools
The implementation experts also developed training and
decision-support tools to promote fidelity to the evi-
dence base. Depression care managers were trained
using the VA Mental Health QUERI Depression Care
Manager Training Manual, which was specifically devel-
oped for the study. A PowerPoint (Microsoft Corpora-
tion, Redmond, WA, USA) slide set was also developed
to facilitate face-to-face training of the depression care
managers. In addition, a web-based decision-support
system (NetDSS) and a NetDSS User’s Guide were speci-
fically developed for the study to promote care manager
fidelity [45]. Difficulty with information technology is
one of the most commonly reported barriers to CCM
adoption, [42] especially information technology sup-
porting symptom monitoring [46]. NetDSS is based on a
highly structured intervention protocol used for a pre-
vious effectiveness study of telemedicine-based CCM
[19]. NetDSS provides context-specific decision support
in real time during patient encounters by guiding care
managers through an evidence-based encounter using
self-scoring instruments, scripts, and clinical algorithms
to identify new medication trials or counseling trials,
treatment phases, and outcome milestones, such as
treatment response (i.e., 50% reduction in symptom
severity), remission (i.e., symptom free), and relapse.
NetDSS is self-documenting and automatically generates
a progress note at the end of the encounter, which was
copied and pasted into the electronic health record.
NetDSS functionality is divided into five categories: (1)
panel management, (2) trial management, (3) clinical
decision support, (4) progress note generator, and (5)
workload/outcomes report generator. NetDSS was con-
tinuously revised based on feedback from the depression
nurse care managers as part of the Plan-Do-Study-Act
process. The NetDSS workload reports were used to
provide fidelity and outcomes data to the EBQI teams
for the Plan-Do-Study-Act process.
Evaluation
The evaluation was based on the RE-AIM (Reach, Effec-
tiveness, Adoption, Implementation, Maintenance) Fra-
mework [47-50]. Reach represents the absolute number/
proportion of eligible/targeted patients who receive the
evidence-based practice [47]. Adoption represents the
absolute number/proportion of staff who use the evi-
dence-based practice [47]. Implementation represents
the fidelity of the evidence-based practice as implemen-
ted in routine care [47]. Effectiveness represents the clin-
ical impact (on patient outcomes) of the evidence-based
practice as implemented in routine care settings [49].
Maintenance represents the degree to which the imple-
mentation of the evidence-based practice is sustained
[47]. To have an impact on health at the population
level, an intervention must be adopted by providers,
reach a large proportion of the targeted patient popula-
tion, be implemented with fidelity, effectively improve
outcomes, and be maintained after research funds are
withdrawn. In addition, we measured implementation
costs.
Adoption
To measure adoption, data were extracted from the
Medical SAS Datasets at the Austin Information Tech-
nology Center. The post-period was defined as the 12
months after each CBOC start date (defined as the date
the first patient was enrolled in the telemedicine-based
CCM program), which ranged from April 2006 to Feb-
ruary 2008. The number of primary care providers at
each CBOC was determined from the SAS Medical
Datasets using unique provider IDs for all types of pri-
mary care providers (e.g., general internist, advance
practice nurse). The number of primary care providers
referring a patient to a depression care manager during
the 12-month post-period was identified from NetDSS.
T h ea d o p t i o nr a t ef o re a c hC B O Cw a sd e f i n e da st h e
total number of primary care providers referring a
patient to the depression care manager (identified from
NetDSS) during the 12-month period divided by the
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during the 12-month period (identified from SAS Medi-
cal Datasets).
Reach
To measure reach, data were extracted from the SAS
Medical Datasets at the Austin Information Technology
Center for the 12-month post-period. Index visits for
patients during the 12-month post-period were defined
as the first primary care encounter at the CBOC with a
depression diagnosis. Patients were excluded if they had
a specialty mental health visit or a diagnosis of bipolar
disorder or schizophrenia during the six months prior
to the CBOC start date or if the index visit was a speci-
alty mental health encounter. The number of patients
referred to the depression care manager during the 12-
month post-period was identified from NetDSS. Reach
during the 12-month post-period at each CBOC was
defined as the total number of patients referred to the
depression care manager (identified from NetDSS)
divided by the total number of patients with a depres-
sion diagnosis who were not already receiving specialty
care (identified in the SAS Medical Datasets).
Implementation/fidelity
To measure fidelity, data were extracted from NetDSS for
the 12-month post-period. NetDSS automatically collects
data about whether care-manager modules were com-
pleted during care-manager encounters. Fidelity during
the acute and continuation phases of treatment was
reported in aggregate using the NetDSS outcomes reports
routine. For the first encounter during the acute phase of
treatment, the fidelity measures included the proportion of
patients receiving education/activation, barrier assess-
ment/resolution, and Patient Health Questionnaire
(PHQ9) depression symptom monitoring. For follow-up
encounters during the acute phase of treatment, fidelity
measures included the proportion of encounters where
self-management goals were discussed, depression symp-
toms were monitored, medication adherence and side-
effects were assessed (for pharmacotherapy and combina-
tion pharmacotherapy/psychotherapy trials only), and
counseling adherence was assessed (for psychotherapy and
combination trials only). In addition, NetDSS reports what
portion of follow-up encounters were completed within
the prespecified timeframe: every two weeks in the acute
phase for pharmacotherapy and combination pharma-
cotherapy/psychotherapy trials, every four weeks for
watchful waiting and psychotherapy-only trials, and every
four weeks for all trials in the continuation phase.
Effectiveness
To measure effectiveness, data were extracted from the
NetDSS final disposition codes for patients enrolled
during the 12-month post-period. Final disposition
codes were as follows: 1 = remitted and completed the
continuation, 2 = responded (> 50% reduction in PHQ9
score) and completed the continuation phase without
relapsing, 3 = unable to complete baseline assessment or
lost to follow-up, 4 = disenrolled at patient’sr e q u e s t ,5
= disenrolled at provider’s request, 6 = became ineligible
(e.g., entered a nursing home or moved away), and 7 =
referred to a higher level of care (e.g., specialty mental
health) due to lack of response or detection of complex
psychiatric comorbidities.
Maintenance
Maintenance represents the sustainability of the teleme-
dicine-based CCM program and the extent to which it
has been institutionalized into the organization’s prac-
tices and policies. Maintenance was measured using two
complementary instruments approximately a year after
the last CBOC enrolled its first patient into the teleme-
dicine-based CCM program, when research funds were
no longer supporting the salary of clinical personnel.
The Level of Use interview [51] measured sustained use
of the program, and the Level of Institutionalization sur-
vey [52] measured the degree to which the program was
institutionalized within the organization. Level of Use
was measured using key informant interviews with the
Medical Directors of each of the 11 CBOCs and the
Chief of Mental Health or Chief of Primary Care at the
VAMC (depending on which service line operated the
program). Using a structured interview guide and induc-
tive questioning, the Level of Use framework classified
the CBOCs into eight ranked levels of adoption accord-
ing to their adoption behaviors. The first three levels
distinguish between stages of nonuse (nonuse, orienta-
tion, and preparation). The next five levels distinguish
between stages of use (mechanical, routine, refinement,
integration, renewal), and these distinctions are made
based on the type of adaptations or refinements that are
being made to the innovation. Level of Institutionaliza-
tion was measured via telephone survey of the Chief of
Mental Health or Chief of Primary Care at the VAMC
(depending on which service line operated the program).
Institutionalization implies that the organization has
modified itself to incorporate the innovation and that
the innovation has ceased to become novel and has
been embedded in standard operating procedures. The
Level of Institutionalization instrument measures an
innovation’s institutionalization among four subsystems:
production, maintenance, supportive, and managerial.
The production subsystem is responsible for delivering
clinical services; to be institutionalized, the innovation
must be integrated with other routine clinical services.
The maintenance subsystem represents personnel; to be
institutionalized, the innovation must be supported by
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sents external organizational forces; to be institutiona-
l i z e d ,t h ei n n o v a t i o nm u s th a v eas t a b l es o u r c eo f
funding and permanent office space. The managerial
subsystem represents the executive and supervisory
functions; to be institutionalized, the innovation must
be assigned to a specific service, staff must have written
job descriptions, and performance measures and pro-
gress reports must be required. For each subsystem, the
Level of Institutionalization survey asks the respondent
about the degree to which the organization has institu-
tionalized the innovation (e.g., supported by permanent
employees), and the responses are averaged to calculate
an overall mean for each subsystem. The Level of Insti-
tutionalization instrument has three levels for each sub-
system: low institutionalization (mean score ≤ 2),
moderate institutionalization (2 < mean score ≤ 3) and
high institutionalization (mean score > 3).
Pre-implementation planning and fixed implementation
costs
Pre-implementation planning costs represent the cost
that a VAMC would incur to implement a telemedicine-
based CCM model in CBOCs. The total cost of attend-
ing EBQI meetings was calculated by multiplying the
number of meetings each EBQI member attended by
their hourly wage estimated from their grade and step
(or nurse level). The total cost of implementation activ-
ities between EBQI meetings was calculated by multiply-
ing the estimated hours per month devoted to
implementation activities by the hourly wage estimated
from grade and step (or nurse level). Fixed implementa-
tion costs represent the one-time cost of implementing
telemedicine-based CCM, including the development of
the VA Mental Health QUERI Depression Care Manager
Training Manual, NetDSS (web-based decision support
system), and the NetDSS User’sG u i d e . These costs were
calculated by estimating the number of hours worked
on each of these activities and from final budget expen-
ditures. These fixed costs would not be incurred for
VAMCs implementing the telemedicine-based CCM
model in CBOCs in the future.
The research was approved by the Institutional Review
Boards of the Central Arkansas Veterans Healthcare
System, the Greater Los Angeles Healthcare System, and
the Loma Linda Healthcare System.
Results
Characteristics of contract community based outpatient
clinics
The characteristics of the 11 participating CBOCs are
presented in Table 1. During the 12-month post-period,
42,330 unique patients were treated at the 11 CBOCs.
The number of patients ranged from 1,325 to 7,411
across the CBOCs, placing the clinics in the small (<
1,500 patients), medium (1,500-5,000 patients), and
large (5,000-10,000 patients) categories. On average, the
percent of patients diagnosed with depression (but with-
out a specialty mental health visit or a diagnosis of bipo-
lar disorder or schizophrenia) ranged from 4.5% to
12.3%, with an average of 7.8% across the CBOCs.
Among this group of patients eligible for depression
care management (n = 3,296), the number of depres-
sion-related primary care encounters per patient during
the 12-month post-period ranged from 1.1 to 1.8, with
an average of 1.3 (standard deviation [SD] = 0.6), which
was about two-thirds of the total number of primary
care encounters. Also among this group, the number of
depression-related specialty mental health visits during
the 12-month post-period ranged from 0.3 to 1.4, with
an average of 0.5 (SD = 1.8), which accounted for about
half of the total number of specialty mental health visits.
Evidence-based quality-improvement process
An average of 11.7 (range = 9-14) staff members partici-
pated in at least one EBQI meeting at each of the
affiliated VAMCs, but only 4.7 (range = 3-6) partici-
pated in five or more EBQI meetings on average. The
duration of the EBQI process averaged 21.3 months
(range = 16-25) across the three VAMCs, and the aver-
age number of EBQI meetings was 13.7 (range = 13-15).
Of those participating in five or more meetings, the
average number of hours per month spent on imple-
mentation efforts was 13.3 (range = 5.5-19.6). Of the
EBQI team members, the depression nurse care man-
agers spent the most hours per month on implementa-
tion efforts (mean = 28.7, range = 16-45).
Collaborative-care management program structure
All three VAMCs chose to include one depression nurse
care manager available by telephone and one supervising
tele-psychiatrist on the CCM team. The two programs
that were operated by Mental Health were able to
obtain psychiatric supervision for the depression care
managers more easily than the site operated by Primary
Care. Other types of providers (e.g., pharmacists, psy-
chotherapists) were not included on any of the CCM
teams. Each VAMC chose to pilot the telemedicine-
based CCM program at one CBOC first and then spread
the program to other CBOCs affiliated with the VAMC.
All three VAMCs chose to enroll only patients who
were referred to the care manager by their primary care
provider. In contrast, none of the VAMCs chose to tar-
get all patients screening positive for depression, or all
patients diagnosed with depression, or all patients initi-
ating antidepressant treatment. However, all three
VAMCs did choose to use an existing Depression Case
Finder to identify patients targeted by VA depression
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and a new antidepressant prescription) and to request
consults (i.e., provider referrals) to the program for
these patients. In addition, care manager clinic codes,
diagnoses, and Current Procedural Terminology (CPT)
codes were chosen to ensure that care manager encoun-
ters contributed to the VA depression follow-up visit
performance measure. All three VAMCs chose to
exclude patients with serious mental illnesses, as well as
patients already receiving (or eventually referred) to spe-
cialty mental health. However, in actuality, care man-
agers sometimes continued to provide care management
to patients referred to their supervising tele-psychiatrist
for ongoing care. Care management activities at all
three VAMCs included education/activation, barrier
assessment/resolution, symptom monitoring, medication
adherence monitoring, side-effects monitoring, and self-
management. All of the VAMCs chose to exclude brief
counseling as a care manager activity to maximize the
caseload capacity of the care manager. None of the
VAMCs developed formal guidelines (e.g., decision
nodes) for referring patients from the telemedicine-
based CCM program to specialty mental health (i.e., to
a higher level of care), but rather, this decision was left
to the discretion of the care manager’s supervising tele-
psychiatrist.
Adoption
There were 84 primary care providers who diagnosed
one or more patients with depression at the implemen-
tation CBOCs during the 12-month post-period.
Approximately 69.0% (58/84) of these providers referred
at least one patient to the depression care manager.
Adoption rates ranged across CBOCs from a low of
33.3% to a high of 100% (see Figure 1).
Reach
There were 3,296 patients diagnosed with depression
(but without a prior specialty mental health visit or a
diagnosis of bipolar disorder or schizophrenia) at imple-
mentation CBOCs during the 12-month post-period.
Nine percent (298/3296) of these patients had an
Table 1 Patterns of depression treatment during the 12-month post-implementation period by study site
Facility Unique
number of
patients
Unique number of
patients diagnosed
with depression
Mean primary
care visits per
patient
Mean primary care
visits for depression
per patient
Mean specialty
mental health visits
per patient
Mean specialty mental
health visits for
depression per patient
VAMC
A
CBOC
1
3474 243
(7.0%)
2.0 1.2 0.8 0.4
CBOC
2
1968 112
(5.7%)
1.9 1.3 1.2 0.8
CBOC
3
4534 487
(10.7%)
1.7 1.3 0.8 0.3
CBOC
4
1325 163
(12.3%)
2.1 1.8 1.8 1.4
VAMC
B
CBOC
5
4545 203
(4.5%)
1.9 1.2 1.6 0.4
CBOC
6
5341 431
(8.1%)
1.7 1.2 1.1 0.6
CBOC
7
7411 673
(9.1%)
1.6 1.3 0.8 0.4
CBOC
8
2374 162
(6.8%)
1.8 1.3 2.0 0.9
CBOC
9
3642 182
(5.0%)
1.8 1.1 0.9 0.5
VAMC
C
CBOC
10
3252 279
(8.6%)
2.0 1.3 1.1 0.6
CBOC
11
4464 361
(8.1%)
2.4 1.4 1.0 0.6
Total 42,330 3,296
(7.8%)
1.9
(SD = 1.2)
1.3
(SD = 0.6)
1.1
(SD = 4.7)
0.5
(SD = 1.8)
VAMC = Department of Veterans Affairs Medical Center; CBOC = Community Based Outpatient Clinic; SD = standard deviation.
VA = Department of Veterans Affairs; CBOC = Community Based Outpatient Clinic.
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Page 7 of 15encounter with a depression care manager. Reach ran-
ged across CBOCs from a low of 1.1% to a high of
49.1% (see Figure 2).
Implementation/fidelity
For most domains, fidelity to the care manager protocol
was excellent for the 298 patients who had encounters
with a depression care manager. Patient education/activa-
tion and barriers assessment/resolution were provided at
100% (298/298) of baseline encounters (i.e., the first care
manager encounter). Likewise, the PHQ9 depression
symptom-monitoring tool was used to assess depression
severity at 100% (298/298) of baseline encounters. The
298 patients had 368 treatment trials in the acute phase.
Almost half (48.4%, 178/368) of the acute phase trials
were pharmacotherapy only, 28.8% (106/368) were com-
bination pharmacotherapy/psychotherapy, 6.3% (23/368)
were psychotherapy only, and 16.6% (61/368) were
watchful waiting. Less than half (42.5%, 681/1603) of fol-
low-up encounters during the acute stage were com-
pleted within the timeframe specified in the acute phase
of treatment (i.e., within two or four weeks, depending
on the trial type). During the acute phase of treatment
for all trials, the PHQ9 symptom-monitoring tool was
used at 100% (681/681) of completed follow-up encoun-
ters, and self-management goals were discussed during
15.3% (104/681) of completed follow-up encounters.
During the acute phase of treatment for pharmacother-
apy and combination trials, medication adherence was
assessed at 99.1% (575/580) of completed follow-up
encounters, and side effects were assessed at 92.4% (536/
580) of completed follow-up encounters. During the
acute phase of treatment for psychotherapy and combi-
nation trials, counseling-session adherence was assessed
Figure 1 Percentage of providers referring to the depression care manager. To measure adoption, data were extracted from the Medical
SAS Datasets at the Austin Information Technology Center. The post-period was defined as the 12 months after each CBOC start date (defined
as the date the first patient was enrolled in the telemedicine-based CCM program), which ranged from April 2006 to February 2008. The number
of primary care providers at each CBOC was determined from the SAS Medical Datasets using unique provider IDs for all types of primary care
providers (e.g., general internist, advance practice nurse). The number of primary care providers referring a patient to a depression care manager
during the 12-month post-period was identified from NetDSS. The adoption rate for each CBOC was defined as the total number of primary care
providers referring a patient to the depression care manager (identified from NetDSS) during the 12-month period divided by the total number
of primary care providers seeing patients during the 12-month period (identified from SAS Medical Datasets).
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Page 8 of 15at 83.3% (239/287) of completed follow-up encounters.
During the continuation phase of treatment, 54.6% (189/
346) of follow-up encounters were completed within the
prespecified timeframe (i.e., within four weeks).
Effectiveness
Depression care managers enrolled 298 patients into the
telemedicine-based CCM program. Of these, 7.4% (22/
298) could not be reached for a baseline evaluation and
another 8.7% (26/298) were lost to follow-up. In addition,
9.7% (29/298) were disenrolled at the patient’s request and
0.3% (1/298) were disenrolled at the primary care provi-
der’s request. Another 7.7% (23/298) became ineligible (e.
g., moved out of area), and 24.2% (72/298) were referred
to a higher level of care (e.g., referred to specialty mental
health). Overall, 18.8% (56/298) remitted (symptom free)
and completed the continuation phase of treatment and
another 22.1% (66/298) responded to treatment and com-
pleted the continuation phase without relapsing. Thus,
40.9% (122/298) of enrolled patients had positive
outcomes because they either remitted or responded and
completed without relapsing. Examining outcomes for
completers only (n = 194), 34.0% (66/194) responded to
treatment and completed, 28.8% (56/194) remitted and
completed (62.8% positive outcomes, 122/194), and 37.1%
(72/194) were referred to a higher level of care.
Maintenance
There was variation across the 11 CBOCs on the Level
of Use instrument. One (9.1%) CBOC was classified as a
nonuser (level 1), two (18.2%) were classified as
mechanical users (level 3), one (9.1%) was classified as a
refinement user (level 6), and seven (63.6%) were classi-
fied as integrated users (level 7) (see Figure 3). Level of
Institutionalization was mostly in the high to moderate
range across all three VAMCs (see Figure 4).
Pre-implementation planning costs and fixed costs
The total cost of attending EBQI meetings was $8,270.90.
The total costs for the time spent on implementation
Figure 2 Percentage of patients referred to the depression care manager. To measure reach, data were extracted from the SAS Medical
Datasets at the Austin Information Technology Center for the 12-month post-period. Index visits for patients during the 12-month post-period
were defined as the first primary care encounter at the CBOC with a depression diagnosis. Patients were excluded if they had a specialty mental
health visit or a diagnosis of bipolar disorder or schizophrenia during the six months prior to the CBOC start date or if the index visit was a
specialty mental health encounter. The number of patients referred to the depression care manager during the 12-month post-period was
identified from NetDSS. Reach during the 12-month post-period at each CBOC was defined as the total number of patients referred to the
depression care manager (identified from NetDSS) divided by the total number of patients with a depression diagnosis who were not already
receiving specialty care (identified in the SAS Medical Datasets).
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Page 9 of 15between EBQI meetings was $84,483.45. The total pre-
implementation planning costs across all three VAMCs
were estimated to be $92,753.79. Dividing total pre-imple-
mentation planning costs by the 3,296 patients diagnosed
with depression at implementation CBOCs and targeted
by the telemedicine-based CCM program during the 12-
month post-period yields a total pre-implementation plan-
ning cost per targeted patient of $28.14. Dividing total
pre-implementation planning costs by the 298 patients
enrolled in the telemedicine-based CCM program during
the 12-month post-period yields a total pre-implementa-
tion planning cost per patient reached of $311.25. The
fixed cost for developing the Mental Health QUERI
Depression Care Manager Training Manual was $17,182.
The fixed cost of developing NetDSS was $100,370. The
fixed cost for developing the NetDSS User’sG u i d ewas
$12,391. The total fixed costs were $129,943.
Discussion
The telemedicine-based CCM program had an excellent
adoption rate by primary care providers (69%), although
reach into the target patient population was relatively
low overall (9%). The low proportion of targeted
patients reached by the program is somewhat difficult to
interpret, as it is not clear what proportion of patients
with depression would have benefited clinically from
depression care management. Moreover, because the
EBQI teams specifically chose to target those patients
whose primary care providers thought would benefit
from the telemedicine-based CCM program, it made it
impossible to identify in a systematic manner what the
true denominator was for the reach evaluation. Presum-
ably, many of the patients diagnosed with depression
(used as the dominator for the reach evaluation) were in
remission or stable on medications during the time per-
iod and would not have benefited clinically from the
program. Of those enrolled in the telemedicine-based
CCM program, fidelity to the care manager protocol
was excellent. The high level of fidelity can be attribu-
ted, in large part, to the use of the NetDSS care man-
ager decision support system. NetDSS workload/
outcomes reports were discussed at EBQI team meetings
Figure 3 Level of use of telemedicine-based collaborative-care management. The Level of Use interview measured sustained use of the
program and was administered approximately a year after the last CBOC enrolled its first patient into the telemedicine-based CCM program,
when research funds were no longer supporting the salary of clinical personnel. Level of Use was measured using key informant interviews with
the Medical Directors of each of the 11 CBOCs and the Chief of Mental Health or Chief of Primary Care at the VAMC (depending on which
service line operated the program). Using a structured interview guide and inductive questioning, the Level of Use framework classified the
CBOCs into eight ranked levels of adoption according to their adoption behaviors. The first three levels distinguish between stages of nonuse
(nonuse, orientation, and preparation). The next five levels distinguish between stages of use (mechanical, routine, refinement, integration,
renewal), and these distinctions are made based on the type of adaptations or refinements that are being made to the innovation.
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Page 10 of 15and used to address problems with care manager fide-
lity. The biggest problems with fidelity were completing
assessments within the prespecified timeframe and care
manager activities that were not required to be com-
pleted by NetDSS (i.e., the optional self-management
planning). In addition, the clinical outcomes of enrolled
patients were comparable to intervention patients in a
prior randomized effectiveness study of telemedicine-
based CCM [19]. Of those enrolled, 18.8% completed
the continuation phase in remission and another 22.1%
responded to treatment and completed the continuation
phase without relapsing. Thus, from an intent-to-treat
perspective, 40.9% of patients enrolled in telemedicine-
based CCM had positive outcomes, which is somewhat
higher than the 12-month intent-to-treat response rate
(36%) reported in a previous randomized effectiveness
trial of telemedicine-based CCM that enrolled patients
screening positive for depression [19]. A previous study
has demonstrated that patients referred to CCM by
their primary care provider as part of routine care
experience greater symptom improvement than those
randomized to CCM after being enrolled in a research
study using traditional recruitment methods [53]. For
those completing the telemedicine-based CCM program,
65.8% either remitted or responded without relapsing.
Importantly, the telemedicine-based CCM programs
continued to be used in a sustained manner after
research funds were withdrawn. Likewise, the telemedi-
cine-based CCM programs became institutionalized into
the operations of the affiliated VAMCs.
Based on these findings, we conclude that EBQI is a
feasible facilitation strategy for contract CBOCs. This
finding is significant because there were many barriers
to adoption in contract CBOCs, and these results are a
Figure 4 Level of institutionalization of telemedicine-based collaborative care management. Level of Institutionalization survey measured
the degree to which the program was institutionalized within the organization. Level of Institutionalization was measured via telephone survey
of the Chief of Mental Health or Chief of Primary Care at the VAMC (depending on which service line operated the program). Institutionalization
implies that the organization has modified itself to incorporate the innovation and that the innovation has ceased to become novel and has
been embedded in standard operating procedures. The Level of Institutionalization instrument measures an innovation’s institutionalization
among four subsystems: production, maintenance, supportive, and managerial. The production subsystem is responsible for delivering clinical
services; to be institutionalized, the innovation must be integrated with other routine clinical services. The maintenance subsystem represents
personnel; to be institutionalized, the innovation must be supported by permanent employees. The supportive subsystem represents external
organizational forces; to be institutionalized, the innovation must have a stable source of funding and permanent office space. The managerial
subsystem represents the executive and supervisory functions; to be institutionalized, the innovation must be assigned to a specific service, staff
must have written job descriptions, and performance measures and progress reports must be required. For each subsystem, the Level of
Institutionalization survey asks the respondent about the degree to which the organization has institutionalized the innovation (e.g., supported
by permanent employees), and the responses are averaged to calculate an overall mean for each subsystem. The Level of Institutionalization
instrument has three levels for each subsystem: low institutionalization (mean score ≤ 2), moderate institutionalization (2 < mean score ≤ 3) and
high institutionalization (mean score > 3).
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method. Rogers has argued that innovation complexity is
a barrier to diffusion, [54,55] and telemedicine-based
CCM is a multifaceted intervention that involves a multi-
disciplinary care team and, thus, is relatively complex to
put into practice. Rogers also argued that incompatibility
can be a barrier to adoption, [54,55] and telemedicine-
based CCM was not compatible with traditional referral-
based treatment patterns of depression treatment in the
VA. Because the VA is an integrated system of care,
referrals from primary care to specialty mental health
care are common, even for mild to moderate depression.
Because CCM encourages a more integrated approach to
care, it was somewhat disruptive to put into practice.
However, there was anecdotal evidence that implement-
ing telemedicine-based CCM in CBOCs was less disrup-
tive than implementing practice-based CCM in parent
VAMCs. This may have been due to the long travel dis-
tance to specialty mental healthcare for CBOC patients,
which may have resulted in the CBOC providers being
less reliant on referrals than primary care providers at
parent VAMCs. The EBQI process also overcame other
barriers to diffusion identified by Rogers, especially trial-
ability [54,55]. Trialability is the degree to which an inno-
vation can be tested on a limited basis and was a barrier
to the adoption because patients can remain in care man-
agement for 6 to 12 months. Piloting telemedicine-based
CCM in the Do phase facilitated the ability to “test drive”
the intervention.
As discussed in the PARiHS framework, context is
also an important factor to the adoption of evidence-
based practices [20]. With respect to external contextual
factors, the sustained implementation of telemedicine-
based CCM was facilitated by the VA’s national Primary
Care/Mental Health Integration Initiative, which concur-
rently promoted the implementation of CCM models.
Even though CCM implementation was only mandated
for the one large CBOC in our sample, the implementa-
tion of the telemedicine-based CCM program was highly
compatible [54,55] with the existing priorities of the VA
Central Office. In contrast to the favorable external con-
text of implementing telemedicine-based CCM, the
internal context of contract CBOCs was a barrier to
implementation. Contract CBOCs are likely to have very
different organizational cultures and climates than
VAMCs and VA-staffed CBOCs. Likewise, because con-
tract CBOCs receive capitated payments, they have a
financial incentive to minimize costs, including both
patient care expenses and the investment of slack
resources in quality-improvement efforts. Although
empirical evidence indicates that telemedicine-based
CCM does not increase primary care visits or costs [54],
the additional cost of collaborating clinically with an
off-site care team may have been a concern of the
primary care providers. This concern may have led to
fewer referrals, thereby contributing to the low level of
reach into the target population.
It is also important to note that the EBQI implemen-
tation strategy was relatively resource intensive. Ignoring
the fixed cost of developing the training materials and
decision support system, the pre-implementation plan-
ning cost per patient reached was $311. It required the
commitment of a large number of busy administrators
and clinicians, as well as the involvement of implemen-
tation researchers. Therefore, the EBQI implementation
strategy used in this study is probably not particularly
scalable. However, assuming that the sites included in
this study are generalizable to other CBOCs, it is prob-
ably not necessary to repeat our relatively resource-
intensive adaption process to spread the telemedicine-
based CCM to other sites [55]. Presumably, much of the
spread to other CBOCs could be more standardized
than it was in this study. A more scalable (i.e., less
intensive) EBQI strategy could also be employed to sup-
port spread, perhaps involving larger groups of CBOCs
in the Plan-Do-Study-Act cycles.
An important limitation of this study is that VAMCs
were chosen based on their willingness to participate
and their potential for success as perceived by VISN lea-
dership. While the results from these implementation
sites may not be generalizable to all VAMCs, it is advi-
sable to initially choose sites that are committed to
implementation for small-scale, multisite evaluation stu-
dies. Similar to an efficacy study, the purpose of small-
scale, multisite evaluation is to determine whether
implementation strategies can work under favorable cir-
cumstances [56]. Generalizability of sites becomes a
more critical issue for region-wide demonstration stu-
dies, where the purpose is to determine whether promis-
ing implementation strategies are effective under a wide
range of contexts [56]. A second limitation was that we
did not have the resources to collect qualitative data
about provider adoption and patient reach. Qualitative
data obtained from key informant interviews with front-
line providers would have helped us better interpret our
quantitative findings about adoption and reach. Another
limitation of the study was that, due to lack of Institu-
tional Review Board oversight at contract CBOCs, on-
site providers and administrators could not be engaged
in research and, therefore, could not participate directly
in the EBQI process. This was an artificial barrier to
implementation that we encountered in the context of
conducting research that would not be an issue outside
this context. Finally, this feasibility study had no com-
parison group that used an alternative implementation
strategy, and thus, we only demonstrated that EBQI can
be successful in this context, not that it was more effec-
tive than other implementation strategies.
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Page 12 of 15The major strength of the evaluation component of
the study was the integration of clinical information
obtained from administrative data and the decision sup-
port system (NetDSS) to measure adoption, reach,
implementation/fidelity, and effectiveness. Likewise,
another strength was measuring maintenance by inte-
grating quantitative and qualitative data obtained from
the Level of Institutionalization survey and the Level of
Use structured key-informant interviews. The major
strength of the implementation component of the study
was development and refinement of the decision support
system (NetDSS), which substantially enhanced care
manager fidelity. The use of NetDSS has spread to non-
study sites at one of the regional VISNs and is now
being used for other mental health disorders. Based on
the results of a previous effectiveness study and the
implementation tools developed for this study, telemedi-
cine-based CCM is now listed on the National Registry
of Evidence-based Programs and Practices (NREPP), a
service of the Substance Abuse and Mental Health Ser-
vices Administration (SAMHSA). NREPP is a searchable
database of interventions, and SAMHSA has developed
this resource to help agencies and organizations imple-
ment evidence-based mental health practices in their
communities.
Conclusions
The results of this study suggest that EBQI can be used
successfully to implement a complex disruptive inter-
vention (telemedicine-based CCM) with fidelity, despite
the organizational barriers in contract CBOCs. The suc-
cess of the EBQI process was likely due to the partner-
ship between clinical leaders and researchers. The
researchers were able to develop evidence-based training
materials and decision-support tools that seemed to pro-
mote fidelity and effectiveness. In turn, the clinical lea-
ders were able to align the telemedicine-based CCM
program with the needs of CBOC staff and patients,
which seemed to promote adoption, reach, and mainte-
nance. Given that EBQI is resource intensive, it may be
a particularly appropriate facilitation strategy during the
early stages of an implementation initiative when a rela-
tively small number of sites are committed to successful
implementation.
Acknowledgements
We would like to thank the depression care managers who participated in
this study: William Raney, Susan Lyrla, and Sue Donovan. We would also like
to thank Cheryl Hardcastle, Kathy Henderson, Amanda Lunsford, Michael
McCarther, Debbie Mittman, Lisa Rubenstein, Barbara Simon, Susan Vivell,
and James Williams for their important contributions to the study.
This research was supported by VA Quality Enhancement Research Initiative
(QUERI) IMV 04-360 grant to Drs. Fortney (PI), Enderle (Co-PI), and McDougall
(Co-PI); the VA HSR&D Center for Mental Health and Outcomes Research; the
VA South Central Mental Illness Research Education and Clinical Center; and
the VA HSR&D Center for the Study of Healthcare Provider Behavior.
Author details
1Health Services Research and Development, Central Arkansas Veterans
Healthcare System, North Little Rock, AR, USA.
2South Central Mental Illness
Research Education and Clinical Center, Central Arkansas Veterans Healthcare
System, North Little Rock, AR, USA.
3Department of Psychiatry, University of
Arkansas for Medical Sciences, Little Rock, AR, USA.
4Office of Quality and
Safety, Department of Veterans Affairs, Washington, DC, USA.
5Desert Pacific
Healthcare Network (VISN 22), Long Beach, CA, USA.
6Behavioral Medicine
Service, VA Loma Linda Healthcare System, Loma Linda, CA, USA.
7Primary/
Ambulatory Care, Greater Los Angeles Healthcare System, Los Angeles, CA,
USA.
8Department of Medicine, University of California, Los Angeles, CA, USA.
9At the time the study was conducted, Dr. Enderle was affiliated with the
South Central Veterans Healthcare Network (VISN 16.
10At the time the study
was conducted, Dr. Clothier was affiliated with the Mental Health Service,
Central Arkansas Healthcare System.
Authors’ contributions
JF obtained funding and contributed to study conceptualization and study
design, acquisition of data, statistical analysis, interpretation of data, and
drafting of the manuscript. ME and SM obtained funding, contributed to
study conceptualization and study design, and critically revised the
manuscript for important intellectual content. JC, JO, and LA supervised the
clinical team, provided administrative leadership, and critically revised the
manuscript for important intellectual content. GC helped with study
conceptualization and study design, collection of Level of Use data from
key-informant interviews, interpretation of data, drafting of manuscript, and
critical revision of the manuscript for important intellectual content. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 30 July 2011 Accepted: 11 April 2012 Published: 11 April 2012
References
1. Katon W, Von Korff M, Lin E, Simon G, Walker E, Unützer J, et al: Stepped
collaborative care for primary care patients with persistent symptoms of
depression: a randomized trial. Arch Gen Psychiatry 1999, 56(12):1109-1115.
2. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, et al: A
multifaceted intervention to improve treatment of depression in primary
care. Arch Gen Psychiatry 1996, 53(10):924-932.
3. Simon GE, VonKorff M, Rutter C, Wagner E: Randomised trial of
monitoring, feedback, and management of care by telephone to
improve treatment of depression in primary care. Br Med J 2000,
320(7234):550-554.
4. Rost K, Nutting P, Smith J, Werner J, Duan N: Improving depression
outcomes in community primary care practice: a randomized trial of the
QuEST intervention. J Gen Intern Med 2001, 16(3):143-149.
5. Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unützer J,
et al: Impact of disseminating quality improvement programs for
depression in managed primary care: a randomized controlled trial. J
Am Med Assoc 2000, 283(2):212-220.
6. Finley PR, Rens HR, Pont JM, Gess SL, Louie C, Bull SA, et al: Impact of
collaborative care model upon depression in primary care: a
randomized controlled trial. Pharmacotherapy 2003, 23:1175-1185.
7. Adler DA, Bungay KM, Wilson IB, Pei Y, Supran S, Peckham E, et al: The
impact of a pharmacist intervention on 6-month outcomes in depressed
primary care patients. Gen Hosp Psychiatry 2004, 26(3):199-209.
8. Unützer J, Katon W, Callahan CM, Williams JW Jr, Hunkeler E, Harpole L,
et al: Collaborative care management of late-life depression in the
primary care setting: a randomized controlled trial. J Am Med Assoc 2002,
288(22):2836-2845.
9. Hedrick SC, Chaney EF, Felker B, Liu CF, Hasenberg N, Heagerty P, et al:
Effectiveness of collaborative care depression treatment in Veteran’s
Affairs primary care. J Gen Intern Med 2003, 18(1):9-16.
10. Badamgarav E, Weingarten SR, Henning JM, Knight K, Hasselblad V, Gano A
Jr, et al: Effectiveness of disease management programs in depression: a
systematic review. Am J Psychiatry 2003, 160(12):2080-2090.
11. Post EP, Metzger M, Dumas P, Lehmann L: Integrating mental health into
primary care within the Veterans Health Administration. Fam Syst Health
2010, 28(2):83-90.
Fortney et al. Implementation Science 2012, 7:30
http://www.implementationscience.com/content/7/1/30
Page 13 of 1512. Panangala SV, Mendez BHP: Veterans Health Administration: Community-
Based Outpatient Clinics. Congressional Research Service 2010, R41044, Ref
Type: Report.
13. Fortney JC, Borowsky SJ, Hedeen AN, Maciejewski ML, Chapko MK: VA
community-based outpatient clinics: access and utilization performance
measures. Med Care 2002, 40(7):561-569.
14. Maciejewski ML, Perkins M, Li YF, Chapko M, Fortney JC, Liu CF: Utilization
and expenditures of Veterans obtaining primary care in community
clinics and VA medical centers: an observational cohort study. BMC
Health Serv Res 2007, 7:56.
15. Liu CF, Chapko MK, Perkins MW, Fortney J, Maciejewski ML: The impact of
contract primary care on health care expenditures and quality of care.
Med Care Res Rev 2008, 65(3):300-314.
16. Chapko M, Borowsky S, Fortney J, Hedeen A, Hoegle M, Maciejewski M,
et al: Evaluation of the Department of Veterans Affairs Community-Based
Outpatient Clinics. Med Care 2002, 40(7):555-560.
17. Fortney J, Pyne JM, Edlund MJ, Williams DK, Robinson DE, Mittal D, et al: A
randomized trial of telemedicine-based collaborative care for
depression. J Gen Intern Med 2007, 22(8):1086-1093.
18. Kitson A, Harvey G, McCormack B: Enabling the implementation of
evidence based practice: a conceptual framework. Qual Health Care 1998,
7(3):149-158.
19. Greenhalgh T: Intuition and evidence-uneasy bedfellows? Br J Gen Pract
2002, 52:395-400.
20. Haynes RB: What kind of evidence is it that Evidence-Based Medicine
advocates want health care providers and consumers to pay attention
to? BMC Health Serv Res 2002, 2:3.
21. Parker LE, Fickel JJ, Yano EM, Simon C, Bonner LM, Ritchie MJ, et al:
Organizational context and adoption of new clinical practices 2009, Ref Type:
Unpublished Work.
22. Steckler A, Goodman RM, Kegler MC: Mobilizing organizations for health
enhancement: Theories of organizational change. In Health Behavior and
Health Education: Theory, Research and Practice. Edited by: Glanz K, Rimmer
BK, Lewis FM. San Francisco, CA: Jossey-Bass; 2002:335-360.
23. Glisson C, Green P: The effects of organizational culture and climate on
the access to mental health care in child welfare and juvenile justice
systems. Administration and Policy in Mental Health and Mental Health
Services Research 2006, 33(4):433-448.
24. Owen RR, Hudson T, Thrush C, Thapa P, Armitage T, Landes RD: The
effectiveness of guideline implementation strategies on improving
antipsychotic medication management for schizophrenia. Med Care 2008,
46(7):686-691.
25. Glisson C: The organizational context of children’s mental health
services. Clin Child Fam Psychol Rev 2002, 5(4):233-253.
26. Glisson C, James LR: The cross-level effects of culture and climate in
human service teams. J Organ Behav 2002, 23:767-794.
27. Schutte K, Yano EM, Kilbourne AM, Wickrama B, Kirchner JE, Humphreys K:
Organizational contexts of primary care approaches for managing
problem drinking. J Subst Abuse Treat 2009, 36(4):435-445, Epub 2008 Nov
12.
28. Rubenstein LV, Chaney EF, Ober S, Felker B, Sherman SE, Lanto A, et al:
Using evidence-based quality improvement methods for translating
depression collaborative care research into practice. Family, Systems &
Health 2010, 28(2):91-113.
29. Rost KM, Duan N, Rubenstein LV, Ford DE, Sherbourne CD, Meredith LS,
et al: The Quality Improvement for Depression collaboration: general
analytic strategies for a coordinated study of quality improvement in
depression care. Gen Hosp Psychiatry 2001, 23(5):239-253.
30. Rubenstein LV, Parker LE, Meredith LS, Altschuler A, de Pillis E, Hernandez J,
et al: Understanding Team-based Quality Improvement for Depression in
Primary Care. Health Serv Res 2002, 37(4):1009-1029.
31. Goldberg HI, Wagner EH, Fihn SD, Martin DP, Horowitz CR, Christensen DB,
et al: A randomized controlled trial of CQI teams and academic
detailing: can they alter compliance with guidelines? Jt Comm J Qual
Improv 1998, 24(3):130-142.
32. Solberg LI, Fischer LR, Wei F, Rush WA, Conboy KS, Davis TF, et al: A CQI
intervention to change the care of depression: a controlled study. Eff
Clin Pract 2001, 4(6):239-249.
33. Parker LE, de Pillis E, Altschuler A, Rubenstein LV, Meredith LS: Balancing
participation and expertise: A comparison of locally and centrally
managed health care quality improvement within primary care
practices. Qual Health Res 2007, 17(9):1268-1279.
34. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O: Diffusion of
innovations in service organizations: systematic review and
recommendations. Milbank Q 2004, 82(4):581-629.
35. Ginsburg LR, Lewis S, Zackheim L, Casebeer A: Revisiting interaction in
knowledge translation. Implementation Science 2007, 2:34.
36. Stange KC, Goodwin MA, Zyzanski SJ, Dietrich AJ: Sustainability of a
practice-individualized preventive service delivery intervention. Am J Prev
Med 2003, 25:296-300.
37. Parker LE, Kirchner JE, Bonner LM, Fickel JJ, Ritchie MJ, Simons CE, et al:
Creating a quality-improvement dialogue: utilizing knowledge from
frontline staff, managers, and experts to foster health care quality
improvement. Qual Health Res 2009, 19(2):229-242.
38. Rubenstein LV, Mittman BS, Yano EM, Mulrow CD: From understanding
health care provider behavior to improving health care: the QUERI
framework for quality improvement. Quality Enhancement Research
Initiative. Med Care 2000, 38(6 Suppl 1):I129-I141.
39. Mendel P, Meredith LS, Schoenbaum M, Sherbourne CD, Wells KB:
Interventions in organizational and community context: a framework for
building evidence on dissemination and implementation in health
services research. Admin Policy Ment Health 2008, 35(1-2):21-37.
40. Meredith LS, Mendel P, Pearson M, Wu S, Joyce G, Straus JB, et al:
Implementation and maintenance of quality improvement for treating
depression in primary care. Psychiatr Serv 2006, 57(1):48-55.
41. Rogers EM: Diffusion of Innovations. New York, NY: The Free Press, A
Division of Simon & Schuster, Inc.;, 5 2003.
42. Fortney JC, Pyne JM, Smith JL, Curran GM, Otero JM, Enderle MA, et al:
Steps for implementing collaborative care programs for depression.
Popul Health Manag 2009, 12(2):69-79.
43. Fortney JC, Pyne JM, Steven CA, Williams JS, Hedrick RG, Lunsford AK, et al:
A web-based clinical decision support system for depression care
management. Am J Manag Care 2010, 16(11):849-854.
44. Franx G, Meeuwissen JA, Sinnema H, Spijker J, Huyser J, Wensing M, et al:
Quality improvement in depression care in the Netherlands: the
depression breakthrough collaborative. A quality improvement report.
International Journal of Integrated Care 2009, 9:e84.
45. Glasgow RE, Vogt TM, Boles SM: Evaluating the public health impact of
health promotion interventions: the RE-AIM framework. Am J Public
Health 1999, 89(9):1322-1327.
46. Glasgow RE, McKay HG, Piette JD, Reynolds KD: The RE-AIM framework for
evaluating interventions: what can it tell us about approaches to
chronic illness management? Patient Educ Couns 2001, 44(2):119-127.
47. Glasgow RE: Translating research to practice: lessons learned, areas for
improvement, and future directions. Diab Care 2003, 26(8):2451-2456.
48. Glasgow RE, Lictenstein E, Marcus AC: Why don’t we see more translation
of health promotion research to practice? Rethinking the efficacy-to-
effectiveness transition. Am J Public Health 2003, 93(8):1261-1267.
49. Hall G, Loucks S, Rutherford W, Newlove B: Levels of use of the
innovation: a framework for analyzing innovation adoption. J Teach Educ
1975, 26(1):52-56.
50. Goodman RM, McLeroy KR: Development of level of institutionalization
scales for health promotion programs. Health Educ Q 1993, 20(2):161-179.
51. Chaney EF, Rubenstein LV, Liu CF, Yano EM, Bolkan C, Lee M, et al:
Implementing collaborative care for depression treatment in primary
care: a cluster randomized evaluation of a quality improvement practice
redesign. Implement Sci 2011, 6:121.
52. Rogers EM: Diffusion of Innovations. New York: The Free Press, A Divison
of Simon & Schuster, Inc.;, 3 1983.
53. Rogers EM: Diffusion of Innovations. 4 edition. New York, NY: The Free Press;
1995.
54. Fortney JC, Maciejewski M, Tripathi S, Deen TL, Pyne JM: A budget impact
analysis of telemedicine-based collaborative care for depression. Med
Care .
55. Smith JL, Williams JW Jr, Owen RR, Rubenstein LV, Chaney E: Developing a
national dissemination plan for collaborative care for depression: QUERI
series. Implement Sci 2008, 3:59.
56. Stetler CB, Mittman BS, Francis J: Overview of the VA Quality
Enhancement Research Initiative (QUERI) and QUERI theme articles:
QUERI Series. Implement Sci 2008, 3(8):1-9.
Fortney et al. Implementation Science 2012, 7:30
http://www.implementationscience.com/content/7/1/30
Page 14 of 15doi:10.1186/1748-5908-7-30
Cite this article as: Fortney et al.: Implementation outcomes of
evidence-based quality improvement for depression in VA community
based outpatient clinics. Implementation Science 2012 7:30.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Fortney et al. Implementation Science 2012, 7:30
http://www.implementationscience.com/content/7/1/30
Page 15 of 15